7 yrs exclusivity in the US for CYP-001 to treat GvHD after FDA approval.
Plus a heap of tax incentives and credits.
Recruitment of second cohort progressing well.
This is large.
Is Sector (Sector Lead) still suspended? He must be doing very well out of this one.
7 yrs exclusivity in the US for CYP-001 to treat GvHD after FDA...
Add to My Watchlist
What is My Watchlist?
